Detonation Nanodiamonds as Promising Drug Carriers

被引:0
作者
R. Yu. Yakovlev
P. G. Mingalev
N. B. Leonidov
G. V. Lisichkin
机构
[1] Russian Academy of Sciences,V. I. Vernadsky Institute of Geochemistry and Analytical Chemistry
[2] M. V. Lomonosov Moscow State University,I. P. Pavlov Ryazan State Medical University
[3] Ministry of Health of the Russian Federation,undefined
来源
Pharmaceutical Chemistry Journal | 2020年 / 54卷
关键词
nanodiamonds; surface modification; drugs; biologically active compounds; conjugates;
D O I
暂无
中图分类号
学科分类号
摘要
Information on the use of detonation nanodiamonds (DNDs) in biomedical applications is reviewed. Literature data and our own results on the preparation of DND conjugates with biologically active compounds and the in vivo distribution of nanodiamonds are presented. The main development directions for designing DND systems to deliver biologically active compounds and drugs are identified. DNDs are attractive for biomedical applications because of their property set that includes biocompatibility, the ability to functionalize the particle surface, strong and specific adsorption/conjugation of drugs and biomolecules, large specific surface area, and stable fluorescence.
引用
收藏
页码:389 / 403
页数:14
相关论文
共 342 条
[1]  
Jahangirian H(2017)undefined Int. J. Nanomed. 12 2957-2978
[2]  
Lemraski EG(2018)undefined Physiol. 234 298-319
[3]  
Webster TJ(2017)undefined Nanotechnology 28 252001-210
[4]  
Mohajeri M(2012)undefined Nat. Commun. 3 700-473
[5]  
Behnam B(2018)undefined Toxicol. Ind. Health 34 200-133
[6]  
Sahebkar A(2010)undefined Regul. Toxicol. Pharmacol. 58 455-2123
[7]  
Cell J(2012)undefined Toxicol. Appl. Pharmacol. 261 121-68
[8]  
Turcheniuk K(2007)undefined Diamond Relat. Mater. 16 2118-18
[9]  
Mochalin VN(2012)undefined Toxicol. Res. 1 62-3591
[10]  
Hong G(2012)undefined Autom. 18 12-86